XML 24 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Millions
Total
Public warrants exercises
Private warrants exchange
Conversion of shares of class B common stock to class A common stock
Class A Common Stock
Class B Common Stock
Common Stock
Class A Common Stock
Common Stock
Class A Common Stock
Public warrants exercises
Common Stock
Class A Common Stock
Private warrants exchange
Common Stock
Class A Common Stock
Conversion of shares of class B common stock to class A common stock
Common Stock
Class B Common Stock
Common Stock
Class B Common Stock
Conversion of shares of class B common stock to class A common stock
Treasury Stock
Additional Paid-In Capital
Additional Paid-In Capital
Public warrants exercises
Additional Paid-In Capital
Private warrants exchange
Additional Paid-In Capital
Conversion of shares of class B common stock to class A common stock
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests
Noncontrolling Interests
Conversion of shares of class B common stock to class A common stock
Beginning balance (in shares) at Dec. 31, 2021             199,523,292       8,560,540                    
Beginning balance at Dec. 31, 2021 $ 1,784.0           $ 0.0       $ 0.0   $ 0.0 $ 1,845.5       $ (131.6) $ (20.7) $ 90.8  
Beginning balance (in shares) at Dec. 31, 2021                         0                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Warrant redemptions / Conversion of shares (in shares)             100     520,000   (520,000)                  
Conversion of shares and warrants exercises/exchange       $ 0.0                         $ 5.1       $ (5.1)
Stock issued for vested restricted stock units (in shares)             220,396                            
Stock compensation to directors in lieu of cash compensation (in shares)             35,046                            
Stock compensation to directors in lieu of cash compensation 0.4                         0.4              
Purchase accounting adjustments to fair value of noncontrolling interests (1.9)                                     (1.9)  
Stock-based compensation expense 31.4                         31.4              
Net loss (288.4)                                 (276.9)   (11.5)  
Other comprehensive loss (58.3)                                   (55.0) (3.3)  
Beginning ending (in shares) at Dec. 31, 2022             200,298,834       8,040,540                    
Ending balance at Dec. 31, 2022 1,467.2           $ 0.0       $ 0.0   $ 0.0 1,882.4       (408.5) (75.7) 69.0  
Ending balance (in shares) at Dec. 31, 2022                         0                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Warrant redemptions / Conversion of shares (in shares)             100     253,207   (253,207)                  
Conversion of shares and warrants exercises/exchange       0.0                         2.1       (2.1)
Stock issued for vested restricted stock units (in shares)             588,274                            
Shares repurchased to satisfy tax withholdings for vesting restricted stock units (in shares)             (149,076)           149,076                
Shares repurchased to satisfy tax withholdings for vesting restricted stock units (1.3)                       $ (1.3)                
Stock compensation to directors in lieu of cash compensation (in shares)             43,636                            
Stock compensation to directors in lieu of cash compensation 0.4                         0.4              
Issuance of shares of class A common stock under a direct registered offering, net of offering costs (in shares)             17,142,857                            
Issuance of shares of class A common stock under a direct registered offering, net of offering costs 149.8                         149.8              
Stock-based compensation expense 21.8                         21.8              
Net loss (98.7)                                 (96.9)   (1.8)  
Other comprehensive loss 10.8                                   10.4 0.4  
Beginning ending (in shares) at Dec. 31, 2023         218,177,832 7,787,333 218,177,832       7,787,333                    
Ending balance at Dec. 31, 2023 $ 1,550.0           $ 0.0       $ 0.0   $ (1.3) 2,056.5       (505.4) (65.3) 65.5  
Ending balance (in shares) at Dec. 31, 2023 149,076                       149,076                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Warrant redemptions / Conversion of shares (in shares)               3,978,418 1,768,000 1,282,448   (1,282,448)                  
Conversion of shares and warrants exercises/exchange   $ 42.3 $ 18.3 $ 0.0                     $ 42.3 $ 18.3 $ 10.6       $ (10.6)
Stock issued for vested restricted stock units (in shares)             819,949                            
Shares repurchased to satisfy tax withholdings for vesting restricted stock units (in shares)             (138,937)           138,937                
Shares repurchased to satisfy tax withholdings for vesting restricted stock units $ (1.9)                       $ (1.9)                
Stock compensation to directors in lieu of cash compensation (in shares)             28,057                            
Stock compensation to directors in lieu of cash compensation 0.3                         0.3              
Stock-based compensation expense 15.3                         15.3              
Net loss (36.6)                                 (36.1)   (0.5)  
Other comprehensive loss (28.6)                                   (27.7) (0.9)  
Beginning ending (in shares) at Dec. 31, 2024         225,915,767 6,504,885 225,915,767       6,504,885                    
Ending balance at Dec. 31, 2024 $ 1,559.1           $ 0.0       $ 0.0   $ (3.2) $ 2,143.3       $ (541.5) $ (93.0) $ 53.5  
Ending balance (in shares) at Dec. 31, 2024 288,013                       288,013